Related Experiment Video
Updated: Aug 16, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Antihypertensive and lipid lowering treatment in stroke prevention: current state and future
Bartłomiej Piechowski-Jóźwiak1, Julien Bogousslavsky
1Department of Neurology, CHUV, Lausanne, Switzerland. bpiechow@amwaw.edu.pl
Insights
Managing vascular risk factors like diabetes and hypertension is crucial for stroke prevention. Further research is needed to clarify the role of hypercholesterolemia and optimize vasoprotective strategies.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Endocrinology
Background:
- Major stroke risk factors include diabetes mellitus, arterial hypertension, and smoking.
- The role of hypercholesterolemia in stroke etiology remains undetermined.
- Intensive glucose-lowering therapy may reduce microvascular complications in type 2 diabetes.
Purpose of the Study:
- To review current understanding of stroke risk factors and preventive strategies.
- To highlight areas requiring further research in vasoprotective therapies for stroke prevention.
Main Methods:
- Review of existing literature on stroke risk factors and management.
- Analysis of evidence regarding glucose-lowering therapies and blood pressure management.
- Identification of knowledge gaps in lipid management and specific drug classes for stroke prevention.
Main Results:
- Blood pressure reduction is recommended for all stroke/TIA patients using various drug classes (diuretics, ACE inhibitors, beta-blockers, calcium antagonists).
- The efficacy of angiotensin II (AT2) receptor blockers in stroke prevention is not yet established.
- Further investigation into novel lipid-lowering agents and combination therapies is warranted.
Conclusions:
- A comprehensive, global approach to managing vascular risk factors is essential for effective stroke prevention.
- Extended follow-up of randomized trials and comparative studies (e.g., ARBs vs. ACE inhibitors) are needed.
- Optimizing vasoprotective strategies through continued research is key to reducing stroke incidence.
Abstract:
Diabetes mellitus, arterial hypertension, smoking are major stroke risk factors. The role of hypercholesterolemia in stroke has not been established yet. In patients with type 2 diabetes mellitus there is evidence that intensive glucose lowering therapy diminishes the risk of microvascular complications. In all patients with stroke or transient ischemic attack (TIA), blood pressure should be lowered irrespectively of the baseline level with either diuretics, angiotensin converting enzyme (ACE) inhibitors, beta-blockers, or calcium antagonists. The role of angiotensin II (AT2) receptor blockers has not been established so far. In general terms a global approach to management of patients with vascular risk factors should be developed. An extended follow-up of randomised trials on preventive therapy should be completed. Controlled trials comparing angiotensin receptor blockers with ACE inhibitors should be started. Further research may focus on the new lipid lowering agents, and on the comparison of single lipid lowering agent vs. combinations in stroke prevention. These efforts should help in finding the best vasoprotective strategy in stroke prevention.
Related Concept Videos
Atherosclerosis III: Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis IV: Nursing Management
Stroke: Introduction and Types
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care